Symic Biomedical Scores $15M
San Francisco-based Symic Biomedical, a developer of therapeutics for chronic disease, has raised $15M in a Series A funding round. The funding was led by Lilly Ventures, and also included
Den Danske Forskningsfond, Mitsui Global Investment, Ally Bridge Group, InCube Ventures, Purdue Foundry Investment Fund, Mission Bay Capital, QB3 Partners, and angels. The company says it has now raised $17.8M in funding in total. The company is led by Ken Horne.
posted on Tuesday, January 6, 2015 (Link to more information)
Related companies:
SYMIC BIOMEDICAL, INC.
Related stories:
> Symic Finds $25M For Biotherapeutics Efforts
> Proteus Biomedical Raises $32M
> Alloy Ventures Invests in Crux Biomedical
> Xlumena Gains $7M
> DNAnexus Snags $58M For Genomic Data Management
silicontap.com Home